Manage — SOD1 Antisense Oligonucleotide
Edit fields and add or remove reviews, snapshots, outcomes, evidence claims, and documents.
Asset fields
Reviews
- Academic · supportive/medium · Neuromuscular panel
Snapshots
- Q2 2025
- Q1 2025
Outcomes
- Clinical entry · 2025-01-10
Evidence claims
- regulatory / Accelerated Approval
- scientific / Target Validation
- translational / Biomarkers
Applications
- D. Whitfield · funded · USD900,000
Funding events
- award · USD900,000 · 2025-01-05
Documents
Application PDFs, reviewer forms, decks — attached as evidence (max 25 MB).
No documents yet.